Conformation-specific alpha-synuclein antibody for Parkinson's research

Ensure your Parkinson’s disease research is at the cutting edge with a conformation-specific alpha-synuclein filament antibody.

In the brains of Parkinson's disease patients, native alpha-synuclein misfolds and aggregates to form filamentous Lewy bodies. Anti-alpha synuclein filament antibody (ab209530) is a conformation-specific antibody that detects aggregated alpha-synuclein.

Anti-alpha synuclein filament antibody [MJFR14-6-4-2] (ab209538):

  • Conformation-specific
    Specifically labels alpha-synuclein filaments/fibrils comprising Lewy bodies.
  • Developed with experts in the field
    Tested and developed in collaboration with The Michael J Fox Foundation (MJFF).
  • Specific, reproducible and reliable
    A recombinant rabbit monoclonal antibody made with RabMAb® technology ensuring specificity, reproducibility and reliability of supply.
  • Suitable for studying other synucleinopathies
    This antibody is also suitable for studying other synucleinopathies such as dementia with Lewy bodies (DLB) and multiple system atrophy (MSA).

Immunohistochemistry (formaldehyde-fixed paraffin-embedded sections) of human DLB brain stained with anti-alpha synuclein filament antibody [MJFR14-6-4-2] (ab209538). Click here for further information on the experimental conditions used for this experiment. Image courtesy of Mr Carl Hobbs, Kings College London.

Sign up